Minnesota

Minneapolis

36,962
Registered Patient Population
0.65%
of Total Population Represented by Patients
8
Total Medical Retail Locations Currently in Operation
4,620 : 1
Patients : Retail

Medical cannabis is legal in Minnesota; however, the smoking of cannabis is prohibited. Patients may use liquid, pill or vaporized delivery methods. Home cultivation is illegal in Minnesota. Patients report limited access due to high costs and an insufficient number of dispensaries.Minnesota does not recognize out of state medical cannabis cards.

Patient Rights and Civil Protection 84/100   
Arrest Protection 40/40
Affirmative Defense 12/15
Parental Rights Protections 10/10
DUI Protections 0/5
Employment Protections 5/5
Explicit Privacy Standards 7/7
Housing Protections 5/5
Does Not Create New Criminal Penalties for Patients 0/5
Organ Transplants 5/5
Reciprocity 0/3
Access to Medicine 48/100   
Allows Distribution Programs 13/40
– Allows Access to Dried Flowers 0/15
– Allows Delivery 0/5
– No Sales Tax or Reasonable Sales Tax 5/5
– Allows for a Reasonable Number of Dispensaries 3/5
– Does Not Require Vertical Integration 0/2
– Ownership/Employment Restrictions 1/2
– Provisions for Labor Standards 0/2
– Environmental Impact Regulations 2/2
– Choice of Dispensary Without Restrictions 2/2
Noncommercial Cultivation 0/20
– Personal Cultivation 0/15
– Collective Gardening 0/5
Explicit Right to Edibles/Concentrates/Other Forms 7/10
Does not Impose Bans or Limits on THC 10/10
Does not Impose Bans on CBD 10/10
Local Bans/Zoning 8/10
Comprehensive Qualifying Conditions 47/50
Adding New Conditions 8/10
– Law/Regulations Allow for New Conditions 5/5
– System Works for Adding New Conditions 3/5
Reasonable Access for Minors 9/10
Reasonable Caregiver Background Checks 3/4
Number of Caregivers 2/2
Patient/Practitioner-Focused Task Force or Advisory Board 2/2
Reasonable Fees (Patients and Caregivers) 7/10
Allows Multiple-Year Registrations 0/2
Reasonable Physician Requirements 3/5
Does Not Classify Cannabis as a Medicine of Last Resort 4/5
Functionality 72/100   
Patients Able to Access Medicine at Dispensaries or by Cultivation 35/50
No Significant Administrative or Supply Problems 12/15
Patients Can Receive Legal Protections Within Reasonable Time Frame of Doctor's Recommendation 8/10
Reasonable Possession Limits 4/5
Reasonable Purchase Limits 5/5
Allows Patients to Medicate Where They Choose 3/5
Covered by Insurance/State Health Aid 0/3
Financial Hardship (Fee Waivers/Discount Medicine) 5/7
Consumer Safety and Provider Requirements 60/100   
Dispensing 21/25
Staff Training 3/5
Standard Operating Procedures 5/5
– Facility Sanitary Conditions 1.25/1.25
– Storage Protocols 1.25/1.25
– Reasonable Security Protocols 1.25/1.25
– Inventory Control 1.25/1.25
Recall Protocol and Adverse Event Reporting 5/5
Product Labeling 2.67/5
– Product Contents, Including Source Material Identification 1.67/1.67
– Allergens 0/1.67
– Potency/Compound Identification 1/1.67
Required Testing 5/5
– Active Compound Identification 1.67/1.67
– Contaminants 1.67/1.67
– Potency 1.67/1.67
Grow/Cultivation 12.25/25
Staff Training 3/5
Standard Operating Procedures 0/5
– Facility and Equipment Sanitary Conditions 0/0.71
– Workforce Safety Protocols 0/0.71
– Storage Protocols (Short-Term and Long-Term Storage) 0/0.71
– Reasonable Security Protocols 0/0.71
– Batch and Lot Tracking 0/0.71
– Disposal/Waste 0/0.71
– Water Management 0/0.71
Pesticide Guidance 3/5
– Pesticide Guidance 2/2.5
– Pesticide Labeling 1/2.5
Required Testing 1.25/5
– Active Ingredient Identification 1.25/1.25
– Contaminants 0/1.25
– Potency 0/1.25
– Sample Retention 0/1.25
Recall Protocol and Adverse Event Reporting 5/5
Manufacturing 18.67/25
Staff Training 3/5
Standard Operating Procedures 5/5
– Facility and Equipment Sanitary Conditions 1/1
– Workforce Safety Protocols 1/1
– Storage Protocols 1/1
– Reasonable Security Protocols 1/1
– Batch and Lot Tracking 1/1
Product Labeling 2.67/5
– Product Contents, Including Source Material Identification 1.67/1.67
– Allergens 0/1.67
– Potency and Compound Information 1/1.67
Required Testing 3/5
– Active Ingredient Identification 1/1
– Contaminants 1/1
– Potency 1/1
– Shelf Life Testing 0/1
– Sample Retention 0/1
Recall Protocol and Adverse Event Reporting 5/5
Laboratory Operations 8.32/25
Staff Training 0/5
Method Validation in Accordance with AHP Guidelines 0/5
Result Reporting 0/5
Independent or Third Party 5/5
Standard Operating Procedures and Protocols 3.32/5
– Equipment and Instrument Calibration 0/0.83
– Sample Tracking 0.83/0.83
– Facility and Equipment Sanitary Conditions 0.83/0.83
– Disposal/Waste 0.83/0.83
– Storage Protocols 0.83/0.83
– Workforce Safety Protocols 0/0.83
Covid Response 15/20   
Delivery Available? 1/6
Curbside Pickup Available? 2/2
Medical Cannabis Essential? 7/7
Telemedicine Available? 5/5
Covid Response 15/20
Delivery Available? 1/6
Curbside Pickup Available? 2/2
Medical Cannabis Essential? 7/7
Telemedicine Available? 5/5
Excerpted from ASA's 2020 State of the States Report.
page icon

Minnesota Medical Marijuana Laws and Regulations

page icon

Becoming a patient in Minnesota

page icon

Recommending Cannabis in Minnesota

page icon

Minnesota Caregiver, Producer and Provider Info

page icon

The State of Medical Marijuana in Minnesota